Michael Caplan, MD
Ophthalmology · Houston, TXNPI 1225034549
Payments from drug & device makers
Across 596 payments — averaging $2385.91 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Johnson & Johnson Surgical Vision, Inc.$934K
- Alcon Research LLC$475K
- Alcon$7K
- Glaukos Corporation$4K
- AbbVie$391
- Carl Zeiss Meditec USA, Inc.$317
- plus $901 from 13 others
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Johnson & Johnson Surgical Vision, Inc. | 78 | $934,038 |
| Alcon Research LLC | 438 | $474,872 |
| Alcon | 29 | $7,003 |
| Glaukos Corporation | 3 | $4,480 |
| AbbVie(2 entities) | 18 | $391 |
| Carl Zeiss Meditec USA, Inc. | 5 | $317 |
| Carl Zeiss Meditec, Inc. | 3 | $207 |
| Rxsight Inc | 3 | $185 |
| Bausch & Lomb Americas Inc. | 3 | $183 |
| Sun Pharmaceutical Industries Inc. | 3 | $63 |
| Oyster Point Pharma, Inc. | 2 | $46 |
| Biotissue Holdings Inc. | 2 | $44 |
| Novartis | 3 | $42 |
| Tarsus Pharmaceuticals, Inc. | 1 | $31 |
| Dompe US, Inc. | 1 | $31 |
| Bausch & Lomb, A Division Of Bausch Health US, LLC | 1 | $21 |
| Aerie Pharmaceuticals, Inc. | 1 | $21 |
| Eyepoint US, Inc. | 1 | $14 |
| Shire North American Group Inc | 1 | $13 |
How this compares
$1,422,002 in reported general payments places this provider in the 95th percentile of 1,355 ophthalmology providers in Texas.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Other ophthalmology in Houston
- David BrownHouston$51.7M
- John MichelettiHouston$3.3M
- Shaheen KavoussiHouston$1.3M
- Kevin JongHouston$1.2M
- Stephen SladeHouston$1.2M
- Rosa TangHouston$1.1M
- Zaina Al-MohtasebHouston$1.1M
- Fiaz ZamanHouston$1M
- Stephen PflugfelderHouston$788K
- Christina WengHouston$722K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.